Latest filing published 23 Jun 2025 for Oric Pharmaceuticals, Inc., €11k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Angie You across 2 companies, led by Oric Pharmaceuticals, Inc. and Sierra Oncology, Inc. Over a trading history stretching from 8 March 2017 to 23 June 2025, the count stands at 3 filings.
Every open-market trade on record is a purchase: 3 purchases worth €269k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2025 alone, the filings show 2 purchases and no sales.
A typical purchase (the median) is worth €41k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 23 June 2025 came the latest disclosure, an open-market purchase for €11k in Oric Pharmaceuticals, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations